Funding
Turn ideas into impact
Show Me
Due: November 18, 2026
Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
Type
Grant
Source
Federal
Opp Number
PAR-25-371
Due: November 18, 2026
Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
Type
Grant
Source
Federal
Opp Number
PAR-25-369
Due: November 19, 2026
Easement Restoration and Stewardship
US $250,000 – $5,000,000
Type
Cooperative Agreement
Source
Federal
Opp Number
USDA-NHQ-ACEP-26-NOFO0001456
Due: November 19, 2026
DoW Toxic Exposures Clinical Trial Award
Type
Grant
Source
Federal
Opp Number
HT942526TERPCTA
Due: November 19, 2026
DoW Toxic Exposures Translational Research Award
Type
Grant
Source
Federal
Opp Number
HT942526TERPTRA
Due: November 19, 2026
DoW Toxic Exposures Investigator Initiated Research Award
Type
Grant
Source
Federal
Opp Number
HT942526TERPIIRA
Due: November 19, 2026
NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional)
Type
Cooperative Agreement
Source
Federal
Opp Number
PAR-25-052
Due: November 19, 2026
Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer’s Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)
Type
Cooperative Agreement
Source
Federal
Opp Number
PAR-25-226
Due: November 23, 2026
Cellular Senescence Network (SenNet): SenNet Data Coordination and Integration Center (SenNet DCIC) (UM1 Clinical Trials Not Allowed)
Type
Cooperative Agreement
Source
Federal
Opp Number
RFA-RM-27-025
Do you have a grant, incentive, funding competition, or other funding source to share?